Zydus Lifesciences Ltd

ZYDUSLIFE

Company Profile

  • Business description

    Zydus Lifesciences Ltd operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients [API] and human formulations. The company's operating segments are: Pharmaceuticals, Consumer Products and Medical Technologies. The majority of revenue is derived from the Pharmaceuticals segment. Geographically, it generates maximum revenue from the United States, followed by India, Europe and other countries.

  • Contact

    Scheme No. 63, Sarkhej-Gandhinagar Highway
    Zydus Corporate Park, Survey No. 536
    Near Vaishnodevi Circle
    Khoraj (Gandhinagar)
    AhmedabadGJ382481
    IND

    T: +91 7948040000

    https://www.zyduslife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    36,827

Stocks News & Analysis

stocks

Lithium’s latest drop and what it means for ASX investors

Volatility returns to the lithium market.
stocks

Major ASX miner remains overvalued following production update

Iron ore strength keeps production on track despite lower copper output.
stocks

Ahead of earnings, is Alphabet stock a buy, a sell, or fairly valued?

From Google Cloud to Gemini user retention, here’s what we expect from Alphabet’s earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,976.9033.400.37%
CAC 408,345.515.400.06%
DAX 4024,902.4055.710.22%
Dow JONES (US)51,839.26307.16-0.59%
FTSE 10010,546.5421.780.21%
HKSE25,132.2910.76-0.04%
NASDAQ25,508.0712.17-0.05%
Nikkei 22566,232.192,091.073.26%
NZX 50 Index13,656.0340.00-0.29%
S&P 5007,443.2814.41-0.19%
S&P/ASX 2008,793.3036.300.41%
SSE Composite Index3,864.3768.091.79%

Market Movers